Oxidative stress might reduce essential fatty acids in erythrocyte membranes of chronic fatigue syndrome patients

Nutritional Neuroscience

Volumn 7, Issue 4, 2004, Pages 251-253

  Nijs, Jo ^a,b   de Meirleir, Kenny ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b Hogeschool Antwerpen   (Belgium)

Author keywords

Chronic fatigue syndrome; Erythrocyte membrane; Nitric oxide; Oxidative stress; Pathophysiology

Indexed keywords

ESSENTIAL FATTY ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PROTEIN KINASE R;

BIOSYNTHESIS; CELL LEVEL; CHRONIC FATIGUE SYNDROME; DIAGNOSTIC PROCEDURE; ENZYME ACTIVATION; ERYTHROCYTE MEMBRANE; HUMAN; HYPOTHESIS; INFECTION; LETTER; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EIF-2 KINASE; ERYTHROCYTE MEMBRANE; FATIGUE SYNDROME, CHRONIC; FATTY ACIDS, ESSENTIAL; HUMANS; NF-KAPPA B; NITRIC OXIDE; OXIDATIVE STRESS;

EID: 12344253717     PISSN: 1028415X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10284150400004148     Document Type: Letter

References (27)

1. Behan, P.O. and Bakheit, A.M.O. (1991) "Clinical spectrum of post-viral fatigue syndrome", British Medical Bulletin 47, 793-808.
2. Bell, E.J., McCartney, R.A. and Riding, M.H. (1988) "Coxsackie B viruses and myalgic encephalomyeltitis", Journal of the Royal Society Medicine 81, 329-331.
3. De Meirleir, K., Bisbal, C., Campine, I., De Becker, P., Salehzada, T., Demettre, E. and Lebleu, B. (2000) "A 37kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome", American Journal of Medicine 108, 99-105.
4. Demettre, E., Bastide, L., D'Haese, A., De Smet, K., De Meirleir, K., Tiev, K.P., Engelbienne, P. and Lebleu, B. (2002) "Ribonuclease L proteolysis in peripheral blood mononuclear cells of chronic fatigue syndrome patients", Journal of Biological Chemistry 277, 35746-35751.
5. Englebienne, P., Frémont, M., Vaeyens, F., Herst, V., Verhas, M., De Becker, P. and De Meirleir, K. (2001) "Chronic fatigue syndrome (CFS) and multiple sclerosis (MS) as subsets of a group of cellular immunity disorders", ME/CFS: The medical practitioners' challenge, Proceedings at Sydney International Conference, 35-42.
6. Fukuda, K., Strauss, S.E., Hickie, I., Sharpe, M.C., Dobbins, J.G., Komaroff, A. and the International Chronic Fatigue Syndrome Study Group (1994) "The chronic fatigue syndrome, a comprehensive approach to its definition and study", Annals of Internal Medicine 121, 953-959.
7. Fulle, S., Mecocci, P., Fano, G., Vecchiet, I., Vecchini, A., Racciotti, D., Cherubini, A., Pizzigallo, E., Vecchiet, L., Senin, U. and Beal, M.F. (2000) "Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome", Free Radical Biology & Medicine 20, 1252-1259.
8. Hickie, I., Lloyd, A. and Wakefield, D. (1995) "Chronic fatigue syndrome: current perspectives on evaluation and management" , Medical Journal of Australia 163, 314-318.
9. Kurup, R.K. and Kurup, P.A. (2003) "Hypothalamic digoxin, cerebral chemical dominance and myalgic encephalomyelitis", International Journal of Neuroscience 113, 683-701.
10. Levy, J. (1994) "Viral studies of chronic fatigue syndrome, introduction", Clinical Infectious Diseases 18, S117.
11. Liu, Z., Wang, D., Xue, Q., Chen, J., Li, Y., Bai, X. and Chang, L. (2003) "Determination of fatty acid levels in eythrocyte membranes of patients with chronic fatigue syndrome", Nutritional Neuroscience 6, 389-392.
12. Mannick, J.B., Asano, K., Izumi, K., Kieff, E. and Stamler, J.S. (1994) "Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation", Cell 79, 1137-1146.
13. Nasralla, M., Haier, J. and Nicolson, G.L. (1999) "Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome", European Journal of Clinical Microbiology and Infectious Diseases 18, 859-865.
14. Nijs, J., Nicolson, G.L., De Becker, P., Coomans, D. and De Meirleir, K. (2002) "High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients", FEMS Immunology Medical Micriobiology 34, 209-214.
15. Pall, M.L. and Satterle, J.D. (2001) "Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome, and post-traumatic stress disorder", Annals of the New York Acadamy of Science 933, 323-329.
16. Piec, G., Mirkovitch, J., Palacio, S., Mühlradt, P.F. and Felix, R. (1999) "Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro", Infection and Immunology 67, 6281-6285.
17. Rawadi, G. (2000) "Mycoplasma fermentans interaction with monocytes/macrophages: molecular basis", Microbes and Infection 2, 955-964.
18. Richards, R.S., Roberts, T.K., McGregor, N.R., Dunstan, R.H. and Butt, H.L. (2000) "Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome", Redox Report: Communication in Free Radical Research 5, 35-41.
19. Sharpe, M.C., Archard, L.C., Banatvala, J.E., Borysiewicz, L.K., Clare, A.W., David, A., Edwards, R.H.T., Hawton, K.E.H., Lambert, H.P., Lane, R.J.M., McDonald, E.M., Mowbray, J.F., Pearson, D.J., Peto, T.E.A., Preedy, V.R., Smith, A.P., Smith, D.G., Taylor, D.J., Tyrell, S.A.J., Wessely, S. and White, P.D. (1991) "A report: chronic fatigue syndrome: guidelines for research", Journal of the Royal Society of Medicine 84, 118-121.
20. Strauss, S.E. (1998) "Chronic fatigue syndrome", In: Fauci, A.S., Braunwald, E., Isselbacker, K.J., Wilson, J.D., Martin, J.B., Kasper, D.L., Hauser, S.L., Longo, D.L. (eds) Harrison's Principles of Internal Medicine, 14th Ed., New York: McGraw-Hill Vol. 2, pp 2483-2485.
21. Suhadolnik, R.J., Reichenbach, N.L., Hitzges, F., Sobol, R.W., Peterson, D.L., Henry, B., Ablashi, D.V., Müller, W.E.G., Schröder, H.C., Carter, A.W. and Strayer, D.R. (1994) " Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome", Clinical Infectious Diseases 18, S96-S104.
22. Takeuchi, O., Kaufmann, A., Grote, K., Kawai, T., Hoshino, K., Morr, M., Muhlradt, P.F. and Akira, S. (2000) "Cutting edge: preferentially the R-stereoisomer of the Mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signalling pathway", Journal of Immunology 164, 554-557.
23. Uetani, K., Der, S.D., Zamanian-Daryoush, M., de la Motte, C., Lieberman, B.Y., Williams, B.R.G. and Erzurum, S.C. (2000) " Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase", Journal of Immunology 165 988-996.
24. Vojdani, A., Choppa, P.C., Tagle, C., Andrin, R., Samini, B. and Lapp, C.W. (1998) "Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with chronic fatigue syndrome", FEMS Immunology and Medical Microbiology 22, 355-365.
25. Warren, G., McKendrick, M. and Peet, M. (1999) "The role of essential fatty acids in chronic fatigue syndrome", Acta Neurological Scandinavica 99, 112-116.
26. Yousef, G.E., Bell, E.J., Mann, G.F., Murugesan, V., Smith, D.G. and McCartney, R.A. (1988) "Chronic enterovirus infection in patients with postviral fatigue syndrome", Lancet 1, 146-150.
27. Zaragoza, C., Ocampo, C.J., Saura, M., McMillan, A. and Lowenstein, C.J. (1997) "Nitric oxide inhibition of coxsackie-virus replication in vitro", Journal of Clinical Investigation 100, 1760-1767.